华润系切入了救命药赛道，寡头市场

和讯网03-28

华润系在国资队伍里是最善于并购整合的，华润东阿阿胶 (000423)、华润三九 (000999)、华润江中、华润怡宝、华润雪花啤酒等都做得很好。在一个寡头市场中，有华润的资金实力与销售能力的加持，博雅生物 (300294)非常有看点。公司刚公布2023年的年报，营业总收入26.5亿元，较上年同期下降3.87%；归属于上市公司股东的净利润为2.37亿元，较上年同期下降45.06%。实际上，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422905155?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-28 08:18","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2422905155","market":"hk","top_or_hot":-1,"title":"华润系切入了救命药赛道，寡头市场","media":"和讯网","content":"<div>\n<p>华润系在国资队伍里是最善于并购整合的，华润 东阿阿胶 (000423)、 华润三九 (000999)、华润江中、华润怡宝、华润雪花 啤酒 等都做得很好。在一个寡头市场中，有华润的资金实力与销售能力的加持， 博雅生物 (300294)非常有看点。公司刚公布2023年的年报，营业总收入26.5亿元，较上年同期下降3.87%；归属于上市公司股东的净利润为2.37亿元，较上年同期下降45.06%。实际上，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032809402387be4161&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华润系切入了救命药赛道，寡头市场</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华润系切入了救命药赛道，寡头市场\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-28 08:18 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032809402387be4161&s=b><strong>和讯网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>华润系在国资队伍里是最善于并购整合的，华润 东阿阿胶 (000423)、 华润三九 (000999)、华润江中、华润怡宝、华润雪花 啤酒 等都做得很好。在一个寡头市场中，有华润的资金实力与销售能力的加持， 博雅生物 (300294)非常有看点。公司刚公布2023年的年报，营业总收入26.5亿元，较上年同期下降3.87%；归属于上市公司股东的净利润为2.37亿元，较上年同期下降45.06%。实际上，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032809402387be4161&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0251144936.SGD","symbol_name":"Fidelity Sustainable Asia Equity A-SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032809402387be4161&s=b","article_id":"2422905155","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032809402387be4161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2422905155","pubTimestamp":1711585095,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"在一个寡头市场中，有华润的资金实力与销售能力的加持， 博雅生物 非常有看点。华润接手后，一方面要处理以前的烂账，另一方面还要不断的剥离非核心业务，逐渐向核心的 血液制品 聚焦。博雅生物在血制品行业中具有领先地位，是行业龙头企业之一。华润正在带着博雅生物整合各方资源，等屁股擦干净了，等浆站资源和并购都实现突破后，就要飞了。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0251144936.SGD":"Fidelity Sustainable Asia Equity A-SGD","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BK1555":"内房股","BK1521":"挪威政府全球养老基金持仓","LU0173614495.USD":"富达中国焦点A","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU2088747998.USD":"EASTSPRING INVESTMENTS ASIA REAL ESTATE MULTI ASSE \"ADM\" (USD) INC","LU0414403682.SGD":"Blackrock Asia Pacific Equity Income A5 SGD-H","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","01109":"华润置地","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU1807302812.USD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (USD) ACC","LU1993786604.SGD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (SGD) ACC","LU1366334578.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"A\" (USD) INC","LU2088747725.USD":"EASTSPRING INVESTMENTS ASIA REAL ESTATE MULTI ASSE \"A\" (USD) ACC","SG9999010078.USD":"UNITED ASIA PACIFIC REAL ESTATE INCOME (USDHDG) INC","LU0880133367.SGD":"UBS (LUX) EQUITY FUND CHINA OPPORTUNITY USD \"P\" (SGD) ACC","LU0048580855.USD":"富达大中华区A","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","LU0791590937.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"A\" (USD)","LU2088748293.HKD":"EASTSPRING INVESTMENTS ASIA REAL ESTATE MULTI ASSE \"AHD\" (HKD) INC","LU0738912210.USD":"Blackrock Asia Pacific Equity Income A6 USD","LU0048597586.USD":"富达亚洲焦点A","LU1366334651.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"I\" (USD) INC","SG9999014674.SGD":"Nikko AM All China Equity A SGD","LU0359201612.USD":"贝莱德中国基金A2","IE0008368742.USD":"首域中国增长基金I Acc","LU2088748020.USD":"EASTSPRING INVESTMENTS ASIA REAL ESTATE MULTI ASSE \"ADM\" (USD) INC A","BK1589":"北水核心资产","SG9999010052.SGD":"United Asia Pacific Real Estate Income Dis SGD","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU0287142896.SGD":"Fidelity China Focus A-SGD","LU0370786039.SGD":"Fidelity Greater China A-SGD","LU0594300419.USD":"富达中国消费基金A","LU2088748376.SGD":"Eastspring Investments - Asia Real Estate Multi Asset Income Cl ASDM SGD-H","BK1570":"华润系","SG9999009997.SGD":"United Asia Pacific Real Estate Income Acc SGD","BK1240":"房地产开发"},"translate_title":"China Resources has cut into the life-saving drug track and oligarch market","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01109":0.9},"content_text":"华润系在国资队伍里是最善于并购整合的，华润 东阿阿胶 (000423)、 华润三九 (000999)、华润江中、华润怡宝、华润雪花 啤酒 等都做得很好。在一个寡头市场中，有华润的资金实力与销售能力的加持， 博雅生物 (300294)非常有看点。公司刚公布2023年的年报，营业总收入26.5亿元，较上年同期下降3.87%；归属于上市公司股东的净利润为2.37亿元，较上年同期下降45.06%。实际上，公司的业绩下降主要是因为计提了2.98亿元的商誉减值，这是因为公司在2015年前后并购了新百药业导致的。如果把计提的减值加回去，净利润同比增长23.8%。公司的商誉减值还没有减值干净，还剩0.8亿元，后面大概要在2024年中报才知道是否减值干净了。华润接手后，一方面要处理以前的烂账，另一方面还要不断的剥离非核心业务，逐渐向核心的 血液制品 聚焦。公司手里持有现金53亿元，没有贷款，非常有钱，具有并购补齐短板的能力。血液制品行业在我国市场规模逐步扩大，预计到2027年中国血制品市场规模将达到780亿元，复合增长率为11.6%。博雅生物在血制品行业中具有领先地位，是行业龙头企业之一。公司的营收和净利润虽然出现了一些滑坡，但经营活动产生的现金流量净额比2022年高一些，现金流还是不错的。华润正在带着博雅生物整合各方资源，等屁股擦干净了，等浆站资源和并购都实现突破后，就要飞了。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422905155"}